메뉴 건너뛰기
Journal of Infection and Chemotherapy
Volumn 15, Issue 6, 2009, Pages 426-427
Procalcitonin and severity of community-acquired pneumonia
Author keywords

Community acquired pneumonia; Procalcitonin
Indexed keywords

PROCALCITONIN;
EID: 76749140455     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0722-8     Document Type: Article
Times cited : (12)
References (6)
  • 1
    • 0027466275 scopus 로고
    • High serum procalcitonin concentrations in patients with sepsis and infection
    • DOI 10.1016/0140-6736(93)90277-N
    • M. Assicot G. Geminique H. Carsin J. Raymond J. Guilbaud C. Bohuon 1993 High serum procalcitonin concentration in patients with sepsis and infection Lancet 341 515 518 10.1016/0140-6736(93)90277-N 1:STN:280:DyaK3s7nt1yjuw%3D%3D 8094770 (Pubitemid 23066085)
    • (1993) Lancet , vol.341 , Issue.8844 , pp. 515-518
    • Assicot, M.1    Gendrel, D.2    Carsin, H.3    Raymond, J.4    Guilbaud, J.5    Bohuon, C.6
  • 3
    • 43549098470 scopus 로고    scopus 로고
    • Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia
    • DOI 10.1016/j.diagmicrobio.2008.01.014, PII S0732889308000667
    • Y. Hirakata K. Yanagihara S. Kurihara K. Izumikawa M. Seki Y. Miyazaki, et al. 2008 Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia Diagn Microbiol Infect Dis 61 170 174 10.1016/j.diagmicrobio.2008.01.014 1:CAS:528:DC%2BD1cXmtVSmsLo%3D 18329217 (Pubitemid 351680368)
    • (2008) Diagnostic Microbiology and Infectious Disease , vol.61 , Issue.2 , pp. 170-174
    • Hirakata, Y.1    Yanagihara, K.2    Kurihara, S.3    Izumikawa, K.4    Seki, M.5    Miyazaki, Y.6    Kohno, S.7
  • 4
    • 44949176523 scopus 로고    scopus 로고
    • Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia
    • 10.1016/j.annemergmed.2008.01.003 18342993
    • D.T. Huang L.A. Weissfeld J.A. Kellum D.M. Yealy L. Kong M. Martino, et al. 2008 Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia Ann Emerg Med 52 48 58 10.1016/j.annemergmed.2008. 01.003 18342993
    • (2008) Ann Emerg Med , vol.52 , pp. 48-58
    • Huang, D.T.1    Weissfeld, L.A.2    Kellum, J.A.3    Yealy, D.M.4    Kong, L.5    Martino, M.6
  • 5
    • 33344460255 scopus 로고    scopus 로고
    • Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia
    • DOI 10.1007/s00134-005-0047-8
    • N. Boussekey O. Leroy S. Alfandari P. Devos H. Georges B. Guery 2006 Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia Intensive Care Med 32 469 472 10.1007/s00134-005-0047-8 1:CAS:528: DC%2BD1cXhtVOnur7K 16477418 (Pubitemid 43289660)
    • (2006) Intensive Care Medicine , vol.32 , Issue.3 , pp. 469-472
    • Boussekey, N.1    Leroy, O.2    Alfandari, S.3    Devos, P.4    Georges, H.5    Guery, B.6
  • 6
    • 44249106864 scopus 로고    scopus 로고
    • Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia
    • DOI 10.1111/j.1440-1843.2008.01293.x
    • J.S. Tseng M.C. Chan J.Y. Hsu B.I.T. Kuo C.L. Wu 2008 Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia Respirology 13 505 509 10.1111/j.1440-1843.2008.01293.x 18422867 (Pubitemid 351725285)
    • (2008) Respirology , vol.13 , Issue.4 , pp. 505-509
    • Tseng, J.-S.1    Chan, M.-C.2    Hsu, J.-Y.3    Kuo, B.I.-T.4    Wu, C.-L.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.